1SantM,A llemani C,Berrino F,Coleman MP,Aareleid T,Chaplain G,et al.Breast cancer survival in Europe and the United States[].Cancer.2004
2O lsen AH,N jor S,VejborgW,et al.Breast cancermortality in Copenhagen after introduction of mammography screening: cohort study[].British Medical Journal.2005
3Hebert-Croteau N,Brisson J,Latreille J,R ivard M,Abdelaziz N,Martin G.Compliance with consensus recommendations for system ic therapy is associated with improved survival of women with node-negative breast cancer[].Journal of Clinical Oncology.2004
4Coombes RC,Hall E,G ibson LJ,Paridaens R,Jassem J,Delozier T,et al.A random ised trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer[].The New England Journal of Medicine.2004
5Goss PE,Ingle JN,Martino S,Robert NJ,Muss HB,P iccartMJ,et al.A random ised trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer[].The New England Journal of Medicine.2003
6B lanks RG,Moss SM,McGahan CE,Quinn MJ,Babb PJ.Effect of NHS breast screening programme on mortality from breast cancer in England and W ales 1990-8: comparison of observed with pred icted mortality[].British Medical Journal.2000
7Sotiriou C,Neo SY,McShane LM,Korn EL,Long PM,Jazaeri A,et al.Breast cancer classification and prognosis based on gene expression profiles from a population-based study[].Proceedings of the National Academy of Sciences of the United States of America.2003
8Sainsbury R,Johnston C,Howard B.Effect on survival of delays in referral of patients with breast cancer symptoms: a retrospective analysis[].The Lancet.1999
9Early Breast Cancer Trials Collaborative Group.Polychemotherapy for early breast cancer: an overview of random ised trials[].The Lancet.1998
